DK145223B - METHOD FOR PREPARING 7-CHLOR-2,3-DIHYDRO-5-PHENYL-1H-1,4-BENZODIAZEPINE DERIVATIVES OR ACID ADDITION SALTS THEREOF - Google Patents

METHOD FOR PREPARING 7-CHLOR-2,3-DIHYDRO-5-PHENYL-1H-1,4-BENZODIAZEPINE DERIVATIVES OR ACID ADDITION SALTS THEREOF Download PDF

Info

Publication number
DK145223B
DK145223B DK307472A DK307472A DK145223B DK 145223 B DK145223 B DK 145223B DK 307472 A DK307472 A DK 307472A DK 307472 A DK307472 A DK 307472A DK 145223 B DK145223 B DK 145223B
Authority
DK
Denmark
Prior art keywords
mixture
dihydro
phenyl
chloro
vacuo
Prior art date
Application number
DK307472A
Other languages
Danish (da)
Other versions
DK145223C (en
Inventor
J Hellerbach
G Zanetti
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK145223B publication Critical patent/DK145223B/en
Application granted granted Critical
Publication of DK145223C publication Critical patent/DK145223C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)

Description

(19) DANMARK (®M(19) DENMARK (®M

_t_ \Ray_t_ \ Ray

^ 02) FREMLÆGGELSESSKRIFT (11) 145223 B^ 02) PRESENTATION WRITING (11) 145223 B

DIREKTORATET FOR PATENT- OG VAREMÆRKEVÆSENETDIRECTORATE OF THE PATENT AND TRADEMARKET SYSTEM

(21) Ansøgning nr. 307V72 (51) lnt.CI* C 07 D 243/16 (22) Indleveringsdag 20. jun. 1972 (24) Løbedag 20. jun. 1972 (41) Aim. tilgængelig 2J. dec. 1972 (44) Fremlagt 11. okt. 1982 (86) International ansøgning nr. -(86) International indleveringsdag “ (85) Videreførelsesdag -(62) Stamansøgning nr. -(21) Application No. 307V72 (51) lnt.CI * C 07 D 243/16 (22) Filing date 20 Jun. 1972 (24) Race day 20 Jun. 1972 (41) Aim. available 2J. December 1972 (44) Submitted Oct 11 1982 (86) International application # - (86) International filing day “(85) Continuation day - (62) Master application no -

(30) Prioritet 22. jun. 1971* 9106/71, CH(30) Priority Jun 22 1971 * 9106/71, CH

(71) Ansøger F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT, 4002 Basel, CH.(71) Applicant F.HOFFMANN-LA ROCHE & CO. AKTIENGESELLSCHAFT, 4002 Basel, CH.

(72) Opfinder Joseph Hellerbach, CH: Guldo Zanetti, CH.(72) Inventor Joseph Hellerbach, CH: Guldo Zanetti, CH.

(74) Fuldmægtig Ingeniørfirmaet Budde, Schou & Co.(74) Associate Engineering Company Budde, Schou & Co.

(54) Fremgangsmåde til fremstilling af 7-chlor-2,3-dihydro-5-phe= nyl-1 H-1,4-benzodiazepinderi= vater eller syreadditlonssalte deraf.(54) Process for the preparation of 7-chloro-2,3-dihydro-5-phenyl-1H-1,4-benzodiazepine derivatives or acid additon salts thereof.

Den foreliggende opfindelse angår en særlig fremgangsmåde til fremstilling af 7-chlor-2,3-dihydro-l-methyl-5-phenyl*·The present invention relates to a particular process for the preparation of 7-chloro-2,3-dihydro-1-methyl-5-phenyl *

-1H-1,4-benzodiazepin eller 7-chlor-2,3-dihydro-5-phenyl-lH-l,4-Q-1H-1,4-benzodiazepine or 7-chloro-2,3-dihydro-5-phenyl-1H-1,4-Q

^ -benzodiazepin eller syreadditionssalte deraf. Disse kendte for- M bindeiser har antikonvulsive, muskelafslappende og tranquilise- ^ rende egenskaber. De virker psykisk aflastende, stemningsudlig- nende og vegetativt regulerende.2 -benzodiazepine or acid addition salts thereof. These known compound compounds have anticonvulsant, muscle relaxant and tranquilizing properties. They seem mentally relieving, mood-relieving and vegetatively regulating.

Fremgangsmåden ifølge den foreliggende opfindelse er έ ejendommelig ved, at en forbindelse med den almene formelThe process of the present invention is characterized by a compound of the general formula

DD

2 1452232 145223

RR

N— CB-^— C NN— CB - ^ - C N

C1^%^\C=0 IC1 ^% ^ \ C = 0 I

ό i hvilken R betyder hydrogen eller methyl, hydrogeneres katalytisk i nærværelse af Raney-nikkel eller Raney-cobalt, hvorefter den fremkomne forbindelse eventuelt omdannes til et til farmaceutiske formål anvendeligt syreadditionssalt.ό in which R represents hydrogen or methyl is catalytically hydrogenated in the presence of Raney nickel or Raney cobalt, and the resulting compound is optionally converted into an acid addition salt useful for pharmaceutical purposes.

Den katalytiske hydrogenering af en forbindelse med formlen I kan gennemføres i et indifferent opløsningsmiddel. Eksempler på sådanne indifferente opløsningsmidler er alkanoler, fortrinsvis methanol eller ethanol, ethere, fortrinsvis dioxan, hvortil der eventuelt kan sættes vand, eller dimethylformamid. Såfremt reaktionen ikke gennemføres i en autoklav, udføres den hensigtsmæssigt ved en temperatur på mellem 10°C og 40°C. Såfremt der arbejdes ved højere temperaturer, f.eks.' 100°C, gennemføres omsætningen i en autoklav. En særligt fore-trukken reaktionstemperatur er stuetemperatur.The catalytic hydrogenation of a compound of formula I can be carried out in an inert solvent. Examples of such inert solvents are alkanols, preferably methanol or ethanol, ethers, preferably dioxane, to which may be added water, or dimethylformamide. If the reaction is not carried out in an autoclave, it is conveniently carried out at a temperature between 10 ° C and 40 ° C. If working at higher temperatures, e.g. 100 ° C, the reaction is carried out in an autoclave. A particularly preferred reaction temperature is room temperature.

Hydrogeneringen kan gennemføres både ved normaltryk og ved forhøjet tryk. Såfremt hydrogeneringen udføres ved forhøjet tryk, må reaktionsblandingen ligeledes være anbragt i en autoklav. Hydrogeneringen udføres særligt hensigtsmæssigt ved normaltryk.Hydrogenation can be carried out both at normal pressure and at elevated pressure. If the hydrogenation is carried out at elevated pressure, the reaction mixture must also be placed in an autoclave. Hydrogenation is particularly conveniently carried out at normal pressure.

Forbindelserne med formlen I, der ved den her omhandlede fremgangsmåde tjener som udgangsmateriale, fås ud fra 2-methyl-amino-5-chlor-benzophenon eller 2-amino-5-chlor-benzophenon ved omsætning med en halogenacetonitril. Som halogenacetonitriler kan der anvendes chloracetonitril, bromacetonitril og iodacetonitril. Ved denne reaktion tjener f.eks. chloracetonitrilen ikke alene som reaktionsdeltager, men hensigtsmæssigt også samtidig som opløsningsmiddel.The compounds of formula I, which in this process serve as starting material, are obtained from 2-methylamino-5-chloro-benzophenone or 2-amino-5-chloro-benzophenone by reaction with a haloacetonitrile. As haloacetonitriles, chloracetonitrile, bromoacetonitrile and iodoacetonitrile can be used. In this reaction, e.g. the chloroacetonitrile not only as a reaction participant, but also at the same time as a solvent.

Fortrinsvis sættes der ved anvendelse af chloracetonitril et alkalimetalbromid, fortrinsvis natriumbromid, eller et alkalime-taliodid, fortrinsvis natrium- eller kaliumiodid, til reaktionsblandingen; fortrinsvis tilsættes der kaliumiodid. Der kan imidlertid også være andre indifferente opløsningsmidler, f.eks. dimethylformamid, til stede. Denne reaktion udføres hensigtsmæssigt ved forhøjet temperatur, fortrinsvis ved reaktionsblandingens kogetemperatur.Preferably, using chloroacetonitrile, an alkali metal bromide, preferably sodium bromide, or an alkali metal iodide, preferably sodium or potassium iodide, is added to the reaction mixture; preferably potassium iodide is added. However, there may also be other inert solvents, e.g. dimethylformamide, present. This reaction is conveniently carried out at elevated temperature, preferably at the boiling temperature of the reaction mixture.

3 145223 hensigtsmæssigt ved forhøjet temperatur, fortrinsvis ved reaktionsblandingens kogetemperatur.Suitably at elevated temperature, preferably at the boiling temperature of the reaction mixture.

Pra beskrivelsen til USA-patent nr. 3.243.427 kendes der f.eks. fremgangsmåder til fremstilling af 7-chlor-2,3-dihydro-l--methyl-5-phenyl-IH-1,4-benzodiazepin og 7-chlor-2,3-dihydro-5-phenyl-1H-1,4-benzodiazepin. Gennemførelsen af disse syntesemetoder har vist, at disse forbindelser delvis som følge af sidereaktioner ikke fås i sådanne udbytter, som gør disse fremgangsmåder særlig attraktive i storteknikken. Disse fremgangsmåder kræver til dels et kostbart apparatopbud eller omfattende forsigtighedsforanstaltninger som følge af anvendelse af toksiske, korrosive eller eksplosionsdygtige reagenser eller reaktanter. Sådanne ulemper undgås ved den her omhandlede fremgangsmåde, som i storteknikken på simpel måde gør de tilsigtede forbindelser tilgængelige ud fra billige udgangsmaterialer.From the disclosure of U.S. Patent No. 3,243,427, it is known, e.g. processes for preparing 7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine and 7-chloro-2,3-dihydro-5-phenyl-1H-1,4 benzodiazepine. The practice of these synthesis methods has shown that these compounds, in part due to side reactions, are not obtained in such yields, which make these methods particularly attractive in the large-scale technique. These methods require, in part, a costly appliance supply or comprehensive precautions due to the use of toxic, corrosive or explosive reagents or reactants. Such drawbacks are avoided by the method of the present invention, which in the large art simply makes the intended compounds available from cheap starting materials.

De følgende eksempler illustrerer fremgangsmåden ifølge opfindelse nærmere.The following examples further illustrate the process of the invention.

Eksempel 1Example 1

En suspension af 11,4 g (2-benzoyl-4-chlor~N-methylanilino)-aceto-nitril og ca. 5 g Raney-nikkel hydrogeneres i 200 ml alkohol, indtil hydrogenoptagelsen er aftaget. Katalysatoren fraskilles, og filtratet inddampes til tørhed i vakuum ved 4o°C. Remanensen opløses delvis i 700 ml kogende petroleumsether (40-45°C). Det uopløselige stof (1,0 g) fraskilles, og filtratet opvarmes til kogning med 1 g aktivt kul og filtreres. Det aktive kul vaskes yderligere med 200 ml kogende petroleumsether (4o-45°C). Filtratet inddampes til ca. 100 ml. Efter henstand natten over fraskilles den udkrystalliserede 7-chlor-l-methyl- 5-phenyl-2,3-dihydro-lH-l,4-benzodiazepin ved sugning, vaskes med petroleumsether (40-45°C) og tørres. Smp. 100-101°C. Udbytte 70%.A suspension of 11.4 g (2-benzoyl-4-chloro-N-methylanilino) -aceto-nitrile and ca. 5 g of Raney nickel are hydrogenated in 200 ml of alcohol until the hydrogen uptake has subsided. The catalyst is separated and the filtrate is evaporated to dryness in vacuo at 40 ° C. The residue is partially dissolved in 700 ml of boiling petroleum ether (40-45 ° C). The insoluble matter (1.0 g) is separated and the filtrate is heated to boiling with 1 g of activated carbon and filtered. The activated charcoal is further washed with 200 ml of boiling petroleum ether (40 ° -45 ° C). The filtrate is evaporated to ca. 100 ml. After standing overnight, the crystallized 7-chloro-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine is extracted by suction, washed with petroleum ether (40-45 ° C) and dried. Mp. 100-101 ° C. Yield 70%.

Udgangsmaterialet kan fremstilles efter en af de fire følgende metoder: (A) En opløsning af 123 g (0,5 mol) 2-methylamino-5-ehlor- benzophenon i 320 ml chloraeetonitril koges i 20 timer under udelukkelse af fugtighed og under tilbagesvaling. Den mørke opløsning hældes ud i 1,5 1 isvand. Der sættes natriumbicarbonat til blandingen til svagt alkalisk reaktion og ekstraheres med 1 1 eddikeester. Eddikees teropløsningen vaskes med 750 ml vand, og de vandige opløsninger ^ 145223 ekstraheres endnu en gang med 1 liter eddikeester. Eddikeesterfaserne forenes, tørres over magnesiumsulfat, filtreres og inddampes til tørhed i vakuum ved 40°C. Den tilbageblivende olie (150 g) opløses i en 150 ml cyclohexan-methylenehlorid-blanding (1:3) og chromatograferes på 2,5 kg kiselgel (Merck). Eluering af søjlen med en blanding af cy-clohexan og methylenchlorid (1:3) giver, efter at de første fraktioner er kasseret, (2-benzoyl-4-chlor-N-methylanilino)-acetonitril, som omkrystalliseres fra ether. Smp. 68-69°C. Udbytte 52%.The starting material can be prepared by one of the four following methods: (A) A solution of 123 g (0.5 mole) of 2-methylamino-5-ehlorobenzophenone in 320 ml of chloraeetonitrile is boiled for 20 hours, excluding moisture and reflux. The dark solution is poured into 1.5 L of ice water. Sodium bicarbonate is added to the mixture for slightly alkaline reaction and extracted with 1 L of acetic ester. Wash the vinegar solution with 750 ml of water and extract the aqueous solutions again with 1 liter of vinegar ester. The acetic ester phases are combined, dried over magnesium sulfate, filtered and evaporated to dryness in vacuo at 40 ° C. The residual oil (150 g) is dissolved in a 150 ml cyclohexane-methylene anhydride mixture (1: 3) and chromatographed on 2.5 kg of silica gel (Merck). Elution of the column with a mixture of cyclohexane and methylene chloride (1: 3), after discarding the first fractions, gives (2-benzoyl-4-chloro-N-methylanilino) acetonitrile, which is recrystallized from ether. Mp. 68-69 ° C. Yield 52%.

(B) Til en blanding af 24,6 g 2-methylamino-5-chlorbenzo- phenon og 83 g kaliumiodid i 150 ml absolut dimethylformamid sættes der under omrøring og udelukkelse af fugtighed ved 100°C i løbet af 2 timer dråbevis 37*8 g ehloracetonitril. Blandingen omrøres yderligere 1 7 timer ved 100 C og inddampes derefter til tørhed i vakuum ved 70°C. Der sættes til remanensen en opløsning af 80 g natriumthiosulfat i 400 ml vand, og det udfældede produkt ekstraheres med 2 x 300 ml eddikeester. Eddikeesterfaserne vaskes med 2 x 300 ml vand, forenes, tørres over magnesiumsulfat og inddampes til tørhed i vakuum ved 4o°C. Remanensen opløses i 50 ml methanol. Efter henstand i 20 timer ved 4°C fraskilles den udkrystalliserede (2-benzoyl-4-chlor-N-methylanilino)-acetonitril, vaskes med lidt methanol og tørres. Smp. 68-69°C. Moder-luden befries for opløsningsmidlet ved 40°C i vakuum. Remanensen opløses i en 50 ml methylenchlorid-cyclohexan-blanding (3:1) og chromatograferes på 500 g kiselgel (Merck). Eluering af søjlen med en blanding af methylenchlorid og cyclohscan (3:1) giver yderligere (2-benzoyl-4-chlor-N-methylanilino)-aeetonitril med smeltepunkt 68-69°C. Udbytte 81%.(B) To a mixture of 24.6 g of 2-methylamino-5-chlorobenzophenone and 83 g of potassium iodide in 150 ml of absolute dimethylformamide is added dropwise 37 * 8 with stirring and exclusion of humidity at 2 ° C. g ehloroacetonitrile. The mixture is stirred an additional 17 hours at 100 ° C and then evaporated to dryness in vacuo at 70 ° C. A solution of 80 g of sodium thiosulfate in 400 ml of water is added to the residue and the precipitated product is extracted with 2 x 300 ml of vinegar ester. The vinegar ester phases are washed with 2 x 300 ml water, combined, dried over magnesium sulfate and evaporated to dryness in vacuo at 40 ° C. The residue is dissolved in 50 ml of methanol. After standing for 20 hours at 4 ° C, the crystallized (2-benzoyl-4-chloro-N-methylanilino) -acetonitrile is separated off, washed with a little methanol and dried. Mp. 68-69 ° C. The mother liquor is freed from the solvent at 40 ° C in vacuo. The residue is dissolved in a 50 ml methylene chloride-cyclohexane mixture (3: 1) and chromatographed on 500 g of silica gel (Merck). Elution of the column with a mixture of methylene chloride and cyclohscan (3: 1) gives additional (2-benzoyl-4-chloro-N-methylanilino) -aetonitrile, mp 68-69 ° C. Yield 81%.

'(C) Til en blanding af 24,6 g 2-methylamino-5-chlorbenzo- phenon og 75 g natriumiodid i 150 ml absolut dimethylformamid sættes der under omrøring og udelukkelse af fugtighed i løbet af 2 timer dråbevis ved 100°C 37,8 g ehloracetonitril. Blandingen omrøres yderligere i 7 timer ved 100°C og inddampes derpå til tørhed i vakuum ved 70°C. Der sættes til remanensen en opløsning af 80 g natriumthiosulfat i 400 ml vand, og det udfældede produkt ekstraheres mea 2 x 300 ml eddikeester. Eddikeesterfaserne vaskes med 2 x 300 ml vand, forenes, tørres over magnesiumsulfat og inddampes til tørhed i vakuum ved 40°C. Remanensen opløses i en 100 ml methylenchlorid-cyclo-hexan-blanding (3:1) og chromatograferes på 1 kg kiselgel (Merck). Eluering af søjlen med en blanding af methylenchlorid og cyclohexan (3:1) giver (2-benzoyl-4-chlor-N-methylanilino)-acetonitril med smp. 68_69°C. Udbytte 67%.(C) To a mixture of 24.6 g of 2-methylamino-5-chlorobenzophenone and 75 g of sodium iodide in 150 ml of absolute dimethylformamide is added dropwise at 100 ° C 37 with stirring and exclusion of moisture, 8 g ehloroacetonitrile. The mixture is further stirred for 7 hours at 100 ° C and then evaporated to dryness in vacuo at 70 ° C. A solution of 80 g of sodium thiosulfate in 400 ml of water is added to the residue and the precipitated product is extracted with 2 x 300 ml of vinegar ester. The vinegar ester phases are washed with 2 x 300 ml of water, combined, dried over magnesium sulfate and evaporated to dryness in vacuo at 40 ° C. The residue is dissolved in a 100 ml methylene chloride-cyclohexane mixture (3: 1) and chromatographed on 1 kg of silica gel (Merck). Elution of the column with a mixture of methylene chloride and cyclohexane (3: 1) gives (2-benzoyl-4-chloro-N-methylanilino) -acetonitrile, m.p. 68_69 ° C. Yield 67%.

5 145223 (D) En blanding af 12,5 g 2<-methylamino-5-chlorbenzophenon og 55,5 g iodacetonitril i 50 ml absolut dimethylformamid orarøres ved 100°C i 6 timer under udelukkelse af fugtighed. Dimethylformamidet o fjernes i vakuum ved 70 C, og der sættes til remanensen en opløsning af 25 g natriumthiosulfat i 500 ml vand. Det udfældede produkt ekstra-heres med 2 x 500 ml eddikeester. Eddikeesterfaserne vaskes med 2 x 5OO ml vand, forenes, tørres over magnesiumsulfat og inddampes i vakuum ved 40°C. Remanensen opløses i 50 ml methanol. Efter henstand i 20 timer ved 4°C fraskilles den udkrystalliserede (2-benzoyl-4-chlor-N-me-thylanilino)-acetonitril, vaskes med lidt methanol og tørres. Smp. 68-69°C. Moderluden inddampes til tørhed i vakuum ved 4o°C. Remanensen apløses i en 50 ml methylenchlorid- cyclohexan-blanding (5:1) og chroma tograferes på 200 g kiselgel (Merck). Eluering af søjlen med en blanding af methylenchlorid og cyclohexan (5:1) giver yderligere (2-benzoyl-4-chlor-N-methylanilino)-acetonitril med smp. 68-69°C. Udbytte 65%.(D) A mixture of 12.5 g of 2β-methylamino-5-chlorobenzophenone and 55.5 g of iodoacetonitrile in 50 ml of absolute dimethylformamide is stirred at 100 ° C for 6 hours, excluding moisture. The dimethylformamide o is removed in vacuo at 70 ° C and a solution of 25 g of sodium thiosulfate in 500 ml of water is added to the residue. The precipitated product is extracted with 2 x 500 ml vinegar ester. The acetic ester phases are washed with 2 x 50 ml of water, combined, dried over magnesium sulfate and evaporated in vacuo at 40 ° C. The residue is dissolved in 50 ml of methanol. After standing for 20 hours at 4 ° C, the crystallized (2-benzoyl-4-chloro-N-methylanilino) -acetonitrile is separated off, washed with a little methanol and dried. Mp. 68-69 ° C. The mother liquor is evaporated to dryness in vacuo at 40 ° C. The residue is dissolved in a 50 ml methylene chloride-cyclohexane mixture (5: 1) and chromatographed on 200 g of silica gel (Merck). Elution of the column with a mixture of methylene chloride and cyclohexane (5: 1) gives additional (2-benzoyl-4-chloro-N-methylanilino) -acetonitrile, m.p. 68-69 ° C. Yield 65%.

Eksempel 2Example 2

En suspension af 8,5 g (2-benzoyl-4-chlor-N-methylani-lino)-acetonitril og 4 g Raney-cobalt hydrogeneres i 200 ml alkohol ved 60°C og 50 ato. Katalysatoren fraskilles, og filtratet inddampes til tørhed i vakuum. Remanensen opløses i 50 ml eddikeester og chro-matograferes på 200 g kiselgel (Merck). Eluering af søjlen med eddikeester giver 7-chlor-l-methyl-5-phenyl-2,5-dihydro-lH-l,4-benzodiazepin med smp. 100-101°C. Udbytte 64%.A suspension of 8.5 g of (2-benzoyl-4-chloro-N-methylanilino) -acetonitrile and 4 g of Raney cobalt is hydrogenated in 200 ml of alcohol at 60 ° C and 50 ato. The catalyst is separated and the filtrate is evaporated to dryness in vacuo. The residue is dissolved in 50 ml of vinegar ester and chromatographed on 200 g of silica gel (Merck). Elution of the column with vinegar ester gives 7-chloro-1-methyl-5-phenyl-2,5-dihydro-1H-1,4-benzodiazepine, m.p. 100-101 ° C. Yield 64%.

Eksempel 5Example 5

En suspension af 2,6 g N-(2-benzoyl-4-chlorphenyl)-gly-cinonitril og ca. 1 g Raney-nikkel hydrogeneres i 100 ml alkohol, indtil hydrogenoptagelsen aftager. Katalysatoren fraskilles, og filtratet inddampes til tørhed i vakuum. Remanensen opløses i 20 ml eddikeester--methanol-blanding (9:1) og chromatograferes på 50 g kiselgel (Merck). Eluering af søjlen med en blanding af eddikeester og methanol (9:1) giver 7-chlor-5-phenyl-l,2-dihydro-5H-l,4-benzodiazepin med smp. 172-175°C. Udbytte 28%.A suspension of 2.6 g of N- (2-benzoyl-4-chlorophenyl) glycinonitrile and ca. 1 g of Raney nickel is hydrogenated in 100 ml of alcohol until hydrogen uptake subsides. The catalyst is separated and the filtrate is evaporated to dryness in vacuo. The residue is dissolved in 20 ml of vinegar ester - methanol mixture (9: 1) and chromatographed on 50 g of silica gel (Merck). Elution of the column with a mixture of vinegar ester and methanol (9: 1) gives 7-chloro-5-phenyl-1,2-dihydro-5H-1,4-benzodiazepine, m.p. 172-175 ° C. Yield 28%.

Udgangsmaterialet kan fremstilles efter en af de tre følgende metoder: (A) En opløsning af 25,1 g 2-amino-5-chlorbenzophenon i 65 ml chloracetonitril koges under udelukkelse af fugtighed i 2 1/2 time under tilbagesvaling. Den mørkerøde opløsning hældes ud i 500 ml isvand.The starting material can be prepared by one of the following three methods: (A) A solution of 25.1 g of 2-amino-5-chlorobenzophenone in 65 ml of chloroacetonitrile is boiled under moisture exclusion for 2 1/2 hours at reflux. The dark red solution is poured into 500 ml of ice water.

6 1452236 145223

Der sættes natriumbicarbonat til blandingen til svagt alkalisk reaktion. Den udfældede fældning fraskilles og kastes bort. Filtratet ekstraheres med 2 x 250 ml eddikeester. Eddikeesterfaserne vaskes med 100 ml vand, forenes, tørres over magnesiumsulfat, filtreres og inddampes i vakuum til tørhed. Remanensen opløses i 100 ml eyclohexan. Efter henstand i 50 minutter ved stuetemperatur fraskilles den ud-krystalllserede N-(2-benzoyl-4-chlorphenyl)-glycinonltril, vaskes med eyclohexan og omkrystalliseres fra methanol. Smp. 174-176°C.Sodium bicarbonate is added to the mixture for slightly alkaline reaction. The precipitated precipitate is separated and discarded. The filtrate is extracted with 2 x 250 ml vinegar ester. The acetic ester phases are washed with 100 ml of water, combined, dried over magnesium sulfate, filtered and evaporated in vacuo to dryness. The residue is dissolved in 100 ml of eyclohexane. After standing for 50 minutes at room temperature, the crystallized N- (2-benzoyl-4-chlorophenyl) glycinonitrile is separated, washed with eyclohexane and recrystallized from methanol. Mp. 174-176 ° C.

Udbytte 9,6%.Yield 9.6%.

(B) Til en blanding af 23,2 g 2-amino-5-chlorbenzophenon og 85 g kaliumiodid i 150 ml aboslut dimethylformamid sættes der under omrøring og udelukkelse af fugtighed i løbet af 2 1/2 time dråbevis ved 100°C 37*8 g ehloracetonitril. Blandingen omrøres yderligere i 6 timer o o ved 100 C og inddampes derefter i vakuum ved 70 C. Til remanensen sættes der en opløsning af 80 g natriumthiosulfat i 400 ml vand, og det udfældede produkt ekstraheres med 2 x 400 ml eddikeester. Eddikeester-faserne vaskes med 2 x 300 ml vand, forenes tørres over magnesiumsulfat og inddampes til tørhed ved 40°C i vakuum. Omkrystallisation af remanensen fra 400 ml eddikeester-cyelohexan-blanding (1:4) giver N-(2-benzoyl-4-ehlorphenyl)-glycinonitril med smp. 174-176°C. Udbytte 62,5%.(B) To a mixture of 23.2 g of 2-amino-5-chlorobenzophenone and 85 g of potassium iodide in 150 ml of aboslut dimethylformamide is added dropwise at 100 ° C 37 with stirring and exclusion of moisture over a period of 2 1/2 hours. 8 g ehloroacetonitrile. The mixture is further stirred for 6 hours at 100 ° C and then evaporated in vacuo at 70 ° C. To the residue is added a solution of 80 g of sodium thiosulfate in 400 ml of water and the precipitated product is extracted with 2 x 400 ml of vinegar ester. The vinegar ester phases are washed with 2 x 300 ml water, combined, dried over magnesium sulfate and evaporated to dryness at 40 ° C in vacuo. Recrystallization of the residue from 400 ml of acetic acid-cyelohexane mixture (1: 4) gives N- (2-benzoyl-4-ehlorophenyl) glycinonitrile, m.p. 174-176 ° C. Yield 62.5%.

(C) En blanding af 23,2 g 2-amino-5-chlorbenzophenon og 33*3 g iodacetonitril i 50 ml absolut dimethylformamid omrøres ved 100°C i 6 timer under udelukkelse af fugtighed. Dimethylformamidet o fjernes i vakuum ved 70 C, og der sættes en opløsning af 25 g natriumthiosulfat i 300 ml vand til remanensen. Det udfældede produkt ekstraheres med 2 x 400 ml eddikeester. Eddikeesterfaserne vaskes med 2 x 200 ml vand, forenes, tørres over magnesiumsulfat og inddampes i vakuum ved 40 c. Omkrystallisation af remanensen fra 400 ml eddikeester--cyclohexan-blanding (1:4) giver N-(2-benzoyl-4-ehlorphenyl)-glycino-nitril med smp, 174-17β°0, Udbytte 63%.(C) A mixture of 23.2 g of 2-amino-5-chlorobenzophenone and 33 * 3 g of iodoacetonitrile in 50 ml of absolute dimethylformamide is stirred at 100 ° C for 6 hours, excluding moisture. The dimethylformamide o is removed in vacuo at 70 ° C and a solution of 25 g of sodium thiosulfate in 300 ml of water is added to the residue. The precipitated product is extracted with 2 x 400 ml of vinegar ester. The vinegar ester phases are washed with 2 x 200 ml water, combined, dried over magnesium sulfate and evaporated in vacuo at 40 c. Recrystallization of the residue from 400 ml vinegar ester - cyclohexane mixture (1: 4) gives N- ) -glycino-nitrile, m.p., 174-17β ° 0, Yield 63%.

DK307472A 1971-06-22 1972-06-20 PROCEDURE FOR THE PREPARATION OF 7-CHLOR-2,3-DIHYDRO-5-PHENYL-1H-1,4-BENZODIAZEPINE DERIVATIVES OR ACID ADDITION SALTS. DK145223C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH910671 1971-06-22
CH910671A CH551986A (en) 1971-06-22 1971-06-22 7-chloro-2,3-dihydro-(1-methyl)-5-phenyl-1h-1,4-benzodiazepine - prepn - by catalytic hydrogenation of (2-benzoyl 4-chloro-n-methylani

Publications (2)

Publication Number Publication Date
DK145223B true DK145223B (en) 1982-10-11
DK145223C DK145223C (en) 1983-02-28

Family

ID=4348387

Family Applications (1)

Application Number Title Priority Date Filing Date
DK307472A DK145223C (en) 1971-06-22 1972-06-20 PROCEDURE FOR THE PREPARATION OF 7-CHLOR-2,3-DIHYDRO-5-PHENYL-1H-1,4-BENZODIAZEPINE DERIVATIVES OR ACID ADDITION SALTS.

Country Status (13)

Country Link
JP (1) JPS5440557B1 (en)
AR (1) AR192947A1 (en)
AT (1) AT318622B (en)
CA (1) CA966834A (en)
CH (1) CH551986A (en)
DK (1) DK145223C (en)
ES (1) ES404085A1 (en)
FI (1) FI54114C (en)
HU (1) HU163717B (en)
NL (1) NL177594C (en)
NO (1) NO140668C (en)
SE (1) SE397977B (en)
YU (1) YU34526B (en)

Also Published As

Publication number Publication date
CA966834A (en) 1975-04-29
FI54114C (en) 1978-10-10
SE397977B (en) 1977-11-28
NL177594C (en) 1985-10-16
AR192947A1 (en) 1973-03-21
NO140668C (en) 1979-10-17
YU135272A (en) 1979-02-28
NO140668B (en) 1979-07-09
HU163717B (en) 1973-10-27
ES404085A1 (en) 1975-11-16
JPS5440557B1 (en) 1979-12-04
NL7205955A (en) 1972-12-28
NL177594B (en) 1985-05-17
AT318622B (en) 1974-11-11
DK145223C (en) 1983-02-28
CH551986A (en) 1974-07-31
FI54114B (en) 1978-06-30
YU34526B (en) 1979-09-10

Similar Documents

Publication Publication Date Title
US3288797A (en) Lipoic acid derivatives and their preparation
JPH1180142A (en) Production of diphenylalkyl compound
SU674669A3 (en) Method of obtaining ethanol derivatives or salts thereof
JPH0249775A (en) Heterocyclic compound having 6-membered or 7-membered ring and production thereof
DK145223B (en) METHOD FOR PREPARING 7-CHLOR-2,3-DIHYDRO-5-PHENYL-1H-1,4-BENZODIAZEPINE DERIVATIVES OR ACID ADDITION SALTS THEREOF
US3304304A (en) Quinazolone derivatives
SU492076A3 (en) Method for producing substituted guanidine
EP0172141B1 (en) Substituted pyridazinones, method for their preparation, pharmaceutical preparation containing these compounds and their use
NO120370B (en)
US3075975A (en) Anthelmintic distilbazoles and method
ELDERFIELD et al. SYNTHESIS OF 1-AMINOPHENAZINES AND CONVERSION OF THEM TO POTENTIAL ANTIMALARIALS1
AT234103B (en) Process for the preparation of new, benzylindolyl-substituted lower aliphatic acids and their salts and esters
JPH02149550A (en) N-(2-carboxy-3&#39;,4&#39;-dimethoxy-cynnamoyl)-anthranilic acid, and production thereof
US3935221A (en) Substituted fusaric acid derivatives
Battersby et al. Biosynthesis of porphyrins and related macrocycles. Part 12. Vitamin B 12: studies with 1-methylbilanes
US2748120A (en) 2-amino-6-aryl-5, 6-dihydro-4-hydroxy-pyrimidines
US3714172A (en) Process for preparing 2-acetamido-3-benzyloxy or 3-benzylthio-pyridides and derivatives thereof
US2761866A (en) 3-pyridine sulfinic acid and process
IL24192A (en) 1-phenylsulfonyl-2-benzimidazolinones and 1-phenylsulfonyl-2-benzimidazolinethiones and process for their preparation
US2670351A (en) New pyrimidine compounds and proc
DE1806106C3 (en) Process for the preparation of 7-nitro-5-pheny 1-1,3-dihydro-2H-1,4-benzodiazepin-2-one derivatives
SU296319A1 (en)
US2697096A (en) Processes for the production of substituted pyridinium compounds
DE1795372C3 (en) 01/10/68 Japan 1501-68 Process for the preparation of 5- (o-halophenyl) -7-halo-1,3-dihydro-2H-1,4-benzodiazepin-2-ones and 2-aminomethylindoles and their salts
DE1136709B (en) Process for the preparation of 2-oxo-1, 2-dihydro-1, 4-benzodiazepines

Legal Events

Date Code Title Description
PBP Patent lapsed